100,00% ROI REPCF Hair Cloning

Without a product Replicel reached $300 during it's bubble. It's Japanese partner Shiseido still angry in a frosty relationship with Replicel due to lack of delayed funding on REPCF's german trial - is now rumored to make an announcement 2018 using REPCF's IP . Shiseido and Replicel were involved in a deal years ago that concluded Shiseido owns the human population of Asia in regards to marketing and collecting royalties off this hair cloning technology in trade that both companies spend tens of millions of dollars on research and human trials. When Replicel failed to spend Shiseido threatened to sue. Now that the situation has settled the science remains to be showcased. Because it's already been tested. Human trials have been conducted the last 2 years. The company Shiseido is sitting on that data. Whether they are sitting on the biggest cosmetic market on the planet or not is in that data.

At a quick glance you can see the timeline and the run up in price. This technology has a head start in japan being autologous there is NO third phase clinical trial only phase 2.
Excellent long. 100,000 ROI set up. ($1,000 to $1,000,000) if this thing hits it's previous resistance from 12 years ago.
ZH 简体中文
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 繁體中文
AR العربية
HE עברית
首页 股票筛选器 外汇筛选器 加密货币筛选器 财经日历 如何运作 图表功能 网站规则 版主 网站 & 经纪商解决方案 插件 图表库 功能请求 博客 & 新闻 常见问题 帮助 & 维基 Twitter
概述 个人资料设置 账号和账单 我的客服工单 联系支持 已发表观点 粉丝 正在关注 私人消息 聊天 退出